| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 6 | 628 | 275 | 1.5 | - | - | 910.5 |
| - | - | - | - | 6 | 222 | 79.3 | - | - | - | 307.3 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| 1 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 2,730 | 99.5% | -1.57 | 922 | 99.2% |
| Optic-unspecified(R) | 13 | 0.5% | -1.12 | 6 | 0.6% |
| AME(R) | 0 | 0.0% | inf | 1 | 0.1% |
| upstream partner | # | NT | conns Cm-DRA | % In | CV |
|---|---|---|---|---|---|
| Dm-DRA1 (R) | 26 | Glu | 297 | 33.7% | 0.3 |
| MeTu2a (R) | 36 | ACh | 127.7 | 14.5% | 0.4 |
| Cm20 (R) | 13 | GABA | 108.3 | 12.3% | 0.7 |
| R7d | 31 | HA | 45.3 | 5.1% | 0.8 |
| MeVC22 (R) | 2 | Glu | 37 | 4.2% | 0.0 |
| Dm2 (R) | 75 | ACh | 34.7 | 3.9% | 0.5 |
| aMe17e (R) | 1 | Glu | 34.3 | 3.9% | 0.0 |
| Mi15 (R) | 53 | ACh | 27.7 | 3.1% | 0.6 |
| MeTu1 (R) | 33 | ACh | 25.7 | 2.9% | 0.6 |
| MeVC20 (R) | 2 | Glu | 20 | 2.3% | 0.1 |
| Cm28 (R) | 6 | Glu | 17 | 1.9% | 0.4 |
| MeTu3c (R) | 19 | ACh | 11 | 1.2% | 0.4 |
| Cm22 (R) | 10 | GABA | 10 | 1.1% | 0.5 |
| MeTu3b (R) | 12 | ACh | 7 | 0.8% | 0.6 |
| Cm23 (R) | 5 | Glu | 6.7 | 0.8% | 0.6 |
| Cm30 (R) | 2 | GABA | 4.7 | 0.5% | 0.1 |
| MeVC2 (L) | 1 | ACh | 4.3 | 0.5% | 0.0 |
| Cm17 (R) | 4 | GABA | 4.3 | 0.5% | 0.3 |
| MeVPMe13 (L) | 1 | ACh | 3.7 | 0.4% | 0.0 |
| MeVP15 (R) | 7 | ACh | 3.7 | 0.4% | 0.5 |
| Mi10 (R) | 7 | ACh | 3.3 | 0.4% | 0.3 |
| Cm33 (R) | 1 | GABA | 2.7 | 0.3% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 2.3 | 0.3% | 0.0 |
| MeTu2b (R) | 6 | ACh | 2.3 | 0.3% | 0.3 |
| Cm14 (R) | 7 | GABA | 2.3 | 0.3% | 0.0 |
| Cm21 (R) | 5 | GABA | 2.3 | 0.3% | 0.3 |
| Dm8b (R) | 2 | Glu | 1.7 | 0.2% | 0.6 |
| MeVPLo2 (R) | 2 | ACh | 1.7 | 0.2% | 0.2 |
| Cm11a (R) | 2 | ACh | 1.7 | 0.2% | 0.2 |
| Tm_unclear (R) | 1 | ACh | 1.3 | 0.2% | 0.0 |
| Cm1 (R) | 2 | ACh | 1.3 | 0.2% | 0.0 |
| Cm4 (R) | 4 | Glu | 1.3 | 0.2% | 0.0 |
| Dm-DRA2 (R) | 4 | Glu | 1.3 | 0.2% | 0.0 |
| MeTu3a (R) | 4 | ACh | 1.3 | 0.2% | 0.0 |
| MeVC4b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe17a (R) | 1 | unc | 1 | 0.1% | 0.0 |
| Cm27 (R) | 2 | Glu | 1 | 0.1% | 0.3 |
| aMe26 (R) | 2 | ACh | 1 | 0.1% | 0.3 |
| Cm3 (R) | 3 | GABA | 1 | 0.1% | 0.0 |
| Cm-DRA (R) | 3 | ACh | 1 | 0.1% | 0.0 |
| Cm12 (R) | 3 | GABA | 1 | 0.1% | 0.0 |
| MeVP6 (R) | 3 | Glu | 1 | 0.1% | 0.0 |
| R8d | 1 | HA | 0.7 | 0.1% | 0.0 |
| Cm7 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| MeVC8 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| Y3 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| Cm32 (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| MeVPMe12 (R) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| Tm5c (R) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| Cm11d (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| MeVPMe10 (L) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| MeVC27 (L) | 2 | unc | 0.7 | 0.1% | 0.0 |
| MeVC3 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| Tm29 (R) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 0.7 | 0.1% | 0.0 |
| Cm8 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| MeVP3 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeLo3b (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVPMe10 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| aMe4 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm18 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Cm5 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Dm8a (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm30 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Cm25 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVP39 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| R7y | 1 | HA | 0.3 | 0.0% | 0.0 |
| Tm5a (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm11c (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm19 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Cm11b (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVP8 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm29 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| MeVPMe7 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| aMe30 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm-DRA | % Out | CV |
|---|---|---|---|---|---|
| Dm-DRA1 (R) | 26 | Glu | 755.3 | 59.7% | 0.2 |
| Cm22 (R) | 10 | GABA | 209.3 | 16.6% | 0.3 |
| Cm20 (R) | 12 | GABA | 52.7 | 4.2% | 0.8 |
| Dm-DRA2 (R) | 17 | Glu | 28.3 | 2.2% | 0.7 |
| aMe4 (R) | 9 | ACh | 23 | 1.8% | 0.4 |
| Cm14 (R) | 18 | GABA | 17.3 | 1.4% | 0.7 |
| Cm10 (R) | 17 | GABA | 14 | 1.1% | 0.7 |
| Dm8b (R) | 12 | Glu | 13 | 1.0% | 1.8 |
| Dm2 (R) | 19 | ACh | 11 | 0.9% | 0.6 |
| Cm21 (R) | 7 | GABA | 9 | 0.7% | 1.5 |
| Cm8 (R) | 15 | GABA | 8.3 | 0.7% | 0.4 |
| Cm12 (R) | 17 | GABA | 8.3 | 0.7% | 0.5 |
| Cm5 (R) | 12 | GABA | 7.7 | 0.6% | 0.7 |
| Mi15 (R) | 16 | ACh | 7.7 | 0.6% | 0.4 |
| MeVPLo2 (R) | 5 | ACh | 7 | 0.6% | 0.4 |
| Cm3 (R) | 13 | GABA | 6.7 | 0.5% | 0.4 |
| Cm18 (R) | 8 | Glu | 6.3 | 0.5% | 0.5 |
| MeTu1 (R) | 13 | ACh | 6.3 | 0.5% | 0.4 |
| MeVPaMe2 (R) | 1 | Glu | 5.3 | 0.4% | 0.0 |
| MeVP15 (R) | 9 | ACh | 5.3 | 0.4% | 0.5 |
| MeTu2a (R) | 8 | ACh | 4.3 | 0.3% | 0.6 |
| Dm8a (R) | 6 | Glu | 3.7 | 0.3% | 0.5 |
| MeTu3b (R) | 6 | ACh | 3.3 | 0.3% | 0.4 |
| MeTu3c (R) | 4 | ACh | 3 | 0.2% | 0.6 |
| MeVPMe6 (R) | 1 | Glu | 2.7 | 0.2% | 0.0 |
| R7d | 2 | HA | 2.3 | 0.2% | 0.7 |
| Tm5c (R) | 4 | Glu | 2.3 | 0.2% | 0.5 |
| MeVP14 (R) | 4 | ACh | 2.3 | 0.2% | 0.5 |
| Cm4 (R) | 5 | Glu | 2.3 | 0.2% | 0.6 |
| Cm6 (R) | 5 | GABA | 2.3 | 0.2% | 0.3 |
| MeVPMe10 (R) | 2 | Glu | 2 | 0.2% | 0.7 |
| MeTu3a (R) | 4 | ACh | 2 | 0.2% | 0.6 |
| Mi4 (R) | 1 | GABA | 1.7 | 0.1% | 0.0 |
| MeTu2b (R) | 2 | ACh | 1.7 | 0.1% | 0.6 |
| Cm30 (R) | 2 | GABA | 1.7 | 0.1% | 0.2 |
| Cm28 (R) | 2 | Glu | 1.3 | 0.1% | 0.5 |
| aMe5 (R) | 2 | ACh | 1.3 | 0.1% | 0.0 |
| R8d | 1 | HA | 1 | 0.1% | 0.0 |
| Cm35 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm23 (R) | 2 | Glu | 1 | 0.1% | 0.3 |
| MeVP39 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm-DRA (R) | 2 | ACh | 1 | 0.1% | 0.3 |
| MeVPMe3 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| Dm11 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| MeVP63 (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| Tm4 (R) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| Cm11d (R) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| MeVP31 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| MeVPMe5 (R) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| MeVPMe9 (L) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| MeLo6 (R) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| Tm_unclear (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVC27 (L) | 1 | unc | 0.3 | 0.0% | 0.0 |
| Mi17 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Tm6 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| TmY3 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Mi14 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVP3 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| aMe2 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVPMe10 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVP32 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVC20 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm30 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Dm4 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| aMe9 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| aMe12 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| aMe17c (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm5a (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Mi16 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| T2 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm7 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm37 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVP12 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVP6 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Lat1 (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| Dm13 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| Mi18 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| aMe13 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| Cm29 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| MeVC22 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |